The small GTPase Rac1 is a key regulator of cell motility. Multiple mechanisms regulate Rac1 activity including its ubiquitylation and subsequent degradation. Here, we identify the tumour suppressor HACE1 (HECT domain and Ankyrin repeat Containing E3 ubiquitin-protein ligase 1) as an E3 ubiquitin ligase responsible for Rac1 degradation following activation by a migration stimulus. We show that HACE1 and Rac1 interaction is enhanced by hepatocyte growth factor (HGF) signalling, a Rac activator and potent stimulus of cell migration. Furthermore, HACE1 catalyses the poly-ubiquitylation of Rac1 at lysine 147 following its activation by HGF, resulting in its proteasomal degradation. This negative feedback mechanism likely restricts cell motility. Consistent with this, HACE1 depletion is accompanied by increased total Rac1 levels and accumulation of Rac1 in membrane ruffles. Moreover, HACE1-depletion enhances cell migration independently of growth factor stimulation, which may have significance for malignant conversion. A non-ubiquitylatable Rac1 rescues the migration defect of Rac1-null cells to a greater extent than wild-type Rac1. These findings identify HACE1 as an antagonist of cell migration through its ability to degrade active Rac1.
INTRODUCTION
The Rho-family GTPase Rac1 cycles between a GDP-and a GTPbound state. When GTP-bound, it interacts with various molecules that elicit downstream responses. 1 Multiple mechanisms control Rac1 activity including nucleotide binding and hydrolysis catalysed by guanine nucleotide exchange factors and GTPase activating proteins (GAPs), regulation of subcellular localization, modulation of protein levels and post-translational modifications such as prenylation 2 as well as ubiquitin-like (Ubl)-type modifications, including ubiquitylation [3] [4] [5] and SUMOylation. 6 Rac1 degradation by the ubiquitin-proteasome system occurs early during hepatocyte growth factor (HGF)-induced cell scattering 4 and in response to cytotoxic necrotizing factor-1 (CNF-1), 7 both of which activate Rac1. Rac1 ubiquitylation at Lys147 is also stimulated by downstream signalling through JNK, creating a negative feedback loop to terminate Rac1 signalling. 3 More recently, it was shown that ubiquitylation and subsequent degradation of active Rac1 is regulated by caveolin1. 5 Together, these studies imply a mechanism for terminating Rac1 signalling downstream of multiple stimuli. Here, we identify the tumour suppressor HACE1 (HECT domain and Ankyrin repeat Containing E3 ubiquitin-protein ligase 1) as a Rac1-binding protein whose interaction is enhanced by HGF stimulation. Recently, this ligase was also shown to ubiquitylate Rac1 following CNF-1 stimulation. 8 We find that HACE1 antagonizes cell migration through its ability to poly-ubiquitylate active Rac1 at Lys147 triggering degradation. Significantly, HACE1-depletion enhances cell migration independently of growth factor stimulation, which may have significance for malignant conversion.
RESULTS AND DISCUSSION
Identification of HACE1 as an E3 ubiquitin ligase for Rac1 following a migration stimulus To identify novel regulators of Rac1 activity during cell migration, we previously performed tandem affinity purification of protein complexes from MDCKII cells expressing tandem affinity purification-tagged Rac1 following HGF treatment. This identified proteins interacting with Rac1 not only in the presence of HGF 6 but also proteins whose interaction with Rac1 appeared enriched in response to HGF (Supplementary Table I ). Amongst putative Rac1-binding proteins, we identified HACE1, which had previously been identified as an E3 ubiquitin ligase deleted in sporadic Wilms' tumours.
9 HACE1 interacts with Rac1 in cells ( Figure 1a and Supplementary Figures S1A, B) and this interaction was more efficient when Rac1 was in its active form (bound to GTP, Figure 1b ). In addition, activation of the HGF-signalling pathway using an oncogenic form of the Met receptor (Tpr-Met), that does not require addition of HGF for activation, 10, 11 increased this interaction (Supplementary Figure S1C) . Furthermore, the interaction between Rac1 and HACE1 was direct (Figure 1c ). HACE1 comprises a 103-kDa protein containing six N-terminal ankyrin repeats connected via a linker region to a C-terminal HECT domain (Figure 1d ). Rac1 was unable to interact with HACE1-lacking ankyrin repeats (Figure 1e ).
To determine whether HACE1 can act as an E3 ubiquitin ligase for Rac1 in cells we performed ubiquitylation experiments in HEK293T cells. Previous studies have shown that the active form of Rac1 is predisposed to ubiquitin-dependent degradation. HACE1 controls cell migration via Rac1 S Castillo-Lluva et al mutant of HACE1, HACE1C876S, was unable to poly-ubiquitylate Rac1 (Figure 1f and Supplementary Figure S1D ). To investigate whether HACE1 affected the degradation of endogenous Rac1 in epithelial cells, we analysed the Rac1 turnover rate in the presence of cycloheximide, an inhibitor of protein translation. We engineered a doxycycline (dox)-inducible system in MDCKII cells allowing short-term overexpression of HACE1 or HACE1C876S. In agreement with a role for HACE1 in mediating Rac1 degradation, HACE1 overexpression led to a more pronounced decrease in Rac1 levels relative to the control following incubation with cycloheximide for 2-4 h (Figure 1g ). Taken together, these results confirm that HACE1 is a Rac1-interacting protein that ubiquitylates preferentially active Rac1 resulting in its degradation. HACE1 controls cell migration via Rac1 S Castillo-Lluva et al HACE1 promotes the degradation of active Rac1 in response to growth factors Active Rac1 is ubiquitylated and subjected to proteasomemediated degradation during HGF-induced epithelial cell scattering. 4 We tested if HACE1 was responsible for this effect. Addition of dox to the MDCKII HACE1 inducible system promoted the degradation of total Rac1 when cells were simultaneously treated with HGF and cycloheximide for 30 min (Figure 2a and Supplementary Figure S2A ). No changes in total Rac1 levels were observed when the ligase dead form of HACE1 was expressed ( Figure 2a and Supplementary Figure S2B) . Significantly, while Rac1-GTP levels increased in control cells and cells overexpressing the ligase dead form of HACE1 following HGF treatment, no increase was observed in HACE1-overexpressing cells, despite normal activation of the Met-ERK pathway ( Figure 2a and Supplementary Figures S2A, B ). Furthermore, we were able to recover Rac1 activation of HACE1-overexpressing cells following HGF treatment by pre-treatment with the proteasome inhibitor MG132 (Figure 2b ). In addition, activation of the HGF-signalling pathway promoted endogenous Rac1 poly-ubiquitylation, which was modestly enhanced by co-expression of HACE1 ( Figure 2c ). As expected, deletion of the ankyrin repeats domain abolished Rac1 poly-ubiquitylation following stimulation of HGF signalling (Figure 2d ). Furthermore, HACE1 depletion using previously described shRNAHACE1 sequences 13 reduced the poly-ubiquitylation of endogenous Rac1 in response to HGF signalling ( Figure 2e ) and modestly increased total Rac1 levels (Supplementary Figure S2C ).
Active Rac1 is associated with cell membranes. 14, 15 To analyse where Rac1 is targeted by HACE1 we performed fractionation experiments in control or HACE1-overexpressing cells. HACE1 overexpression promoted degradation of Rac1 selectively in the membrane fraction ( Figure 2f ) consistent with the observation that a Rac1 mutant that cannot go to the membrane is not ubiquitylated. 3 Live-cell imaging revealed co-localization of Rac1 and HACE1 at membrane ruffles in MDCKII cells treated with HGF (Figure 2g ) despite the majority of HACE1 being cytoplasmic as previously described. 9 These results demonstrate that HACE1 is required for the poly-ubiquitylation and degradation of active Rac1 associated with membranes in response to HGF.
HACE1-depletion promotes cell migration through Rac1
We next investigated how deregulation of Rac1 degradation would affect cell migration utilizing HACE1-null (KOHACE1) MEFs. These cells expressed increased levels of Rac1 compared with control (WT) MEFs (Figure 3a and Supplementary Figure S3A) indicating that HACE1 can regulate steady-state levels of Rac1 in addition to Rac1 levels following stimulation with HGF. However, we could not see any differences in Cdc42 and RhoA levels between control and HACE1-null MEFs (Supplementary Figure  S3B) . We next analysed migration tracks of single WT and KOHACE1 MEFs. We found that HACE1-null cells migrated faster than control cells (0.3 vs 0.19 mm/min) (Figure 3b and Supplementary Figure S3C) . Immunostaining for endogenous Rac1 and actin in the KOHACE1 MEFs revealed a marked accumulation of actin and Rac1 at the leading edge of migrating cells (Supplementary Figure S3D) . By re-constituting HACE1 expression in the KOHACE1 MEFs we could reverse the increased Rac1 levels (Figure 3a) , the increased migration (Figure 3b and Supplementary Figure S3C ) and the Rac1 accumulation at the leading edge of migrating cells (Supplementary Figure S3D) , indicating that these changes were because of HACE1 depletion. Furthermore, Rac1 depletion in the KOHACE1 MEFs reversed their increased cell migration confirming that this effect was due to an increased level of Rac1 (Figure 3b and Supplementary  Figures S3E, F) .
Previously poly-ubiquitylation of activated Rac1 (Rac1Q61L) was shown to be important for Rac1 dynamics in peripheral membrane ruffles. 5 To test if HACE1 influences Rac1 dynamics at membrane ruffles, WT and KOHACE1 MEFs were transduced with GFP-Rac1WT for 24 h and analysed by live-cell imaging for the localization of Rac1 at membrane ruffles in the leading edge. KOHACE1 cells possessed increased Rac1WT at the leading edge at a given time compared with WT cells (Figures 3c and d) . This was not because of increased membrane thickness at ruffles, as there was no strong co-localization at ruffles between a membrane dye and GFP-Rac1WT (Supplementary Figure S3G) . From these data we infer that the absence of HACE1 results in a more stable Rac1 associated with the membrane.
As anticipated, HGF treatment of WT cells increased their Rac1-GTP levels and their migration speed (Figures 3e, f and Supplementary Figure S3H) . Addition of HGF to KOHACE1 MEFs induced an even greater increase in Rac1-GTP levels (Figure 3e ), but surprisingly did not further enhance migration of these cells (Figure 3f) . Nevertheless, HGF treatment of KOHACE1 MEFs made their migration markedly more persistent compared with control cells (longer tracks, Supplementary Figure S3I) . Interestingly, absence of HACE1 did not markedly affect Rac1 activation at 5 min following HGF treatment (Supplementary Figure S3H) , indicating that HACE1 does not influence the rate or magnitude of Rac1 activation but rather its duration.
Nethe et al. 5 have shown that Caveolin1 depletion results in accumulation of activated Rac1, generation of a flattened Figure 2 . HACE1 promotes the ubiquitylation and degradation of the active form of Rac1 in response to growth factor signalling. (a) MDCKII cells were serum starved and either treated with dox in parallel ( þ dox) for 16 h to induce overexpression of HACE1 or the HACE1C876S mutant or left uninduced ( À dox). Cells were subsequently treated with CHX and where indicated HGF for 30 min before Rac1 activity was measured. Rac1-GTP levels as determined by scanning densitometry were normalized to tubulin and also to the control (0 min; À dox). Bar charts show mean±s.e. of the mean from four independent experiments. *Po0.05, two-tailed Student's t-test. (b) MDCKII cells were treated as in (a) but with or without MG132 for 2 h before Rac1 activity was measured. Rac1-GTP levels were quantified relative to tubulin and also to the control (0 min; À dox; -MG132). Bar charts show mean ± s.e. of the mean from three independent experiments. (c) HEK293T cells were transfected with the indicated plasmids. Ubiquitylated proteins were then purified from lysates by His PD. Endogenous Rac1-nUb was detected by WB in response to activation of HGF signalling by Tpr-Met and in the presence or absence of HACE1. Ubiquitylated Rac1 levels were quantified by scanning densitometry and normalized relative to lane 2. Bar chart shows mean±s.e. of the mean from three independent experiments. *Po0.05, paired-samples t-test. (d) HEK293T cells were transfected with the indicated plasmids and ubiquitylated proteins were purified from lysates by His PD. MYC-Rac1-nUb was detected by WB. '*' Indicates background bands. (e) HEK293T cells were transfected with Scr or HACE1 (N1) shRNA for 3 days and with 6His-Ubiquitin and Tpr-Met for 24 h before the ubiquitylated proteins were purified by His PD. Endogenous Rac1-nUb was detected by WB. (f ) MDCKII cells inducibly overexpressing HACE1 following treatment with doxycycline ( þ dox) for 16 h or non-induced control cells ( À dox) were incubated with CHX for the indicated times and subjected to cell fractionation. Proteins were detected by WB. b-catenin and RhoGDI serve as a control for the membrane and cytosolic fractions, respectively. Total Rac1 bands were quantified and normalized relative to the appropriate control (0 h; À dox; cytosolic or 0 h; À dox; membrane). Bar chart shows mean±s.e. of the mean from three independent experiments. (g) MDCKII cells were transfected with Halo-Rac1WT and GFP-HACE1 and were either treated with HGF for 1 h or left untreated. Cells were labelled with the fluorescent ligand to visualize Halo-tag 1 h before the images were taken. Scale bars, 15 mm. ns, no significant difference.
HACE1 controls cell migration via Rac1
S Castillo-Lluva et al morphology and reduced directional migration of cells plated on fibronectin. They suggested that Caveolin1 could be required to promote Rac1 degradation, but the E3 ligase required for this was not identified. We could not detect an interaction between HACE1
and Caveolin1 (Supplementary Figure S3J) . Furthermore, seeding KOHACE1 MEFs on fibronectin induced a very different phenotype compared with that described for Caveolin1-null MEFs. The KOHACE1 MEFs were very elongated compared with the WT and Quantification of Rac1-GTP was performed by scanning densitometry normalized to total Rac1 and also to control (plastic). Bar chart shows mean ± s.d. from three independent experiments. *Po0.05, two-tailed Student's t-test. ns, no significant difference.
HACE1 controls cell migration via Rac1 S Castillo-Lluva et al this phenotype was reversed when these cells were treated with a Rac1 inhibitor (Figure 3g) . We compared Rac1-GTP levels of KOHACE1 MEFs seeded on plastic or fibronectin and found that cells plated on fibronectin have a 30% increase in Rac1-GTP levels (Figure 3h ), suggesting that the elongated phenotype of the KOHACE1 MEFs on fibronectin is owing to their increased Rac-GTP levels. Together these data suggest that HACE1 is required to control the dynamics of Rac1 at peripheral membrane ruffles and that Caveolin1-and HACE1-mediated degradation of Rac1 seem to be independent. They also reinforce the importance of controlling Rac1 activity by proteasome degradation during cell migration.
HACE1 ubiquitylates Rac1 at Lys147
Previous studies revealed that Rac1 is ubiquitylated at Lys147. 3 To test whether HACE1 induces Rac1 poly-ubiquitylation at this lysine we performed in vitro ubiquitylation assays. We found Rac1Q61L to be ubiquitylated upon incubation with recombinant HACE1 but not upon incubation with recombinant HACE1C876S (Supplementary Figure S4A) . Importantly, recombinant Rac1Q61LK147R mutant was not ubiquitylated by HACE1 (Figure 4a and Supplementary Figure S4A ). Furthermore, Rac1WT or Rac1K147R expression showed that HACE1 induces polyubiquitylation of Rac1 at Lys147 in cells following activation of HGF signalling (Figure 4b ). To investigate the potential connection between Rac1 ubiquitylation and cell migration, we compared the ability of Rac1WT to that of the ubiquitylation defective Rac1K147R mutant to rescue the migration defect of Rac1-null MEFs.
16 Rac1-null MEFs are greatly impaired in their ability to form lamellipodia and have a defect in cell migration. 6, 16 MEFs depleted for Rac1 (KORac1) were transfected with GFP, GFP-Rac1WT or GFP-Rac1K147R and 24 h later GFP positive cells were analysed for the presence of lamellipodia. We found that Rac1WT and Rac1K147R were able to rescue the lamellipodia formation defect of Rac1-null MEFs equally well (Figure 4c) , although due to their highly transitory nature we could not exclude differences in the formation of membrane ruffles. We did not detect a difference in activation of the mutant Rac1K147R compared to Rac1WT in response to HGF (Supplementary Figure S4B) . However, the Rac1K147R mutant was able to rescue the migration defect of Rac1-null cells significantly better than Rac1WT (Figure 4d and Supplementary Figure S4C) . We then investigated Rac1 turnover at peripheral ruffles. We found that the Rac1K147R mutant accumulated markedly more at the periphery of cells compared with the Rac1WT (Figures 4e and f) . These results confirm that Rac1 degradation by the proteasome is responsible for the turnover of Rac1 at membrane ruffles. GTP hydrolysis catalysed by GAPs and consequent inactivation might also induce Rac1 turnover within membrane ruffles. To investigate the relative contribution of Rac1 degradation compared with its inactivation by GAPs in limiting the accumulation of Rac1 in membrane ruffles, we transfected MDCKII cells with Halo-Rac1V12, which is unable to hydrolyse GTP and thus insensitive to GAPmediated inactivation, 17, 18 and performed live-cell imaging. Overexpression of GFP-HACE1 increased the turnover of Rac1V12 within membrane ruffles compared with control cells expressing Halo-Rac1V12 and GFP only (Supplementary Figures S4D, E) . Thus, degradation alone can result in Rac1 turnover in membrane ruffles.
In conclusion, we have shown that HACE1 is a Rac1-binding protein responsible for poly-ubiquitylation and proteasomemediated degradation of Rac1 following HGF treatment. In particular, HACE1 selectively targets active Rac1 associated with membrane protrusions, antagonizing migration. Disrupting the control of Rac1 degradation by depletion of HACE1 results in the accumulation of Rac1 in membrane protrusions and promotes cell migration. Significantly, we found that the enhanced migration of HACE1-null cells can be reversed by knock-down of Rac1, implying that Rac1 is essential and perhaps solely responsible for the enhanced motility of HACE1-null cells. Moreover, we showed that the motility of HACE1-null cells was not further enhanced by HGF treatment, despite additional increase in active Rac1 levels. A number of factors could account for this: one potential is that levels of Rac1 GAPs in HACE1-null cells required for Rac1 to cycle between GTP-and GDP-bound states become limiting and that such cycling is possibly needed for optimal cell migration. A second potential is that the amount of effector molecules required for cell migration becomes limiting. Human tumours frequently downregulate HACE1 expression and HACE1-null mice develop spontaneous malignancies. 13 Our data indicate that loss of HACE1 function may contribute to the invasive phenotype of cancer cells through allowing enhanced migration without the need for growth factor stimulation.
HACE1 has been independently identified as an E3 ubiquitin ligase required for Rac1 degradation in response to cytotoxic necrotizing factor-1, 8 a bacterial toxin that activates Rho proteins in host cells. 7 This study did not focus, as we have done here, on the role of HACE1-mediated Rac ubiquitylation in regulating cell migration. Also the lysine targeted by HACE1 for ubiquitylation was not identified. Our results demonstrate that HACE1 is required for the poly-ubiquitylation of Rac1 activated in response to HGF on Lys147 and its subsequent degradation. Therefore, together with the study of Torrino et al. 8 the data suggest that HACE1 targets active Rac1 for proteasomal degradation independently of the stimulus used for its activation. Additionally Oberoi et al. 19 recently demonstrated the ability of inhibitors of apoptosis proteins (IAPs) to ubiquitylate Rac1 at Lys147 leading to its degradation. IAPs were found to associate equally with Rac1-GDP and Rac1-GTP. Moreover, the interaction between IAPs and Rac1 was not enhanced following HGF treatment of cells, in contrast to what we have demonstrated here for HACE1. Therefore, it is possible that IAPs are not involved in HGF-induced migration. Nonetheless, as with HACE1 depletion, depletion of IAPs promotes constitutive cell migration and thus these two ligases may have non-redundant roles in certain contexts.
MATERIALS AND METHODS
Materials and methods are described in the Supplementary Information.
